EC Number |
Inhibitors |
Structure |
---|
1.14.14.86 | (1E)-1-[4-(4-butyl-1H-1,2,3-triazol-1-yl)phenyl]-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pent-1-en-3-ol |
- |
|
1.14.14.86 | (2R,3R)-paclobutrazol |
- |
|
1.14.14.86 | (2S,3S)-paclobutrazol |
- |
|
1.14.14.86 | (5E)-6-tert-butyl-5-[(4-chlorophenyl)methylidene]-5,6-dihydro-8H-[1,2,4]triazolo[5,1-c][1,4]oxazine |
- |
|
1.14.14.86 | (5E)-6-tert-butyl-5-[(4-nitrophenyl)methylidene]-5,6-dihydro-8H-[1,2,4]triazolo[5,1-c][1,4]oxazine |
- |
|
1.14.14.86 | abscinazole-F1 |
- |
|
1.14.14.86 | DSI-505ME |
- |
|
1.14.14.86 | methyl (2E)-3-[1-[(1E)-1-(4-chlorophenyl)-3-hydroxy-4,4-dimethylpent-1-en-2-yl]-1H-imidazol-5-yl]prop-2-enoate |
- |
|
1.14.14.86 | paclobutrazol |
- |
|
1.14.14.86 | paclobutrazol racemate |
- |
|